Partnerships

Collaboration and Licensing Extends the Reach of Our Technology 

Arrowhead actively engages in collaboration and licensing agreements with leading biotechnology and pharmaceutical companies to advance the development and commercialization of our Targeted RNAi Molecule (TRiM™) platform and our drug candidates. Partnerships allow Arrowhead to tap external expertise to complement our internal research and development, create commercialization opportunities in areas outside of our core focus, and provide capital to help fund our fully owned pipeline.

Smart and selective partnering supports a key Arrowhead goal to bring as many life-changing therapies to patients as possible, in the most efficient and expeditious manner. We currently have collaborations with many of the leading pharmaceutical companies.

If you are interested in collaborating with Arrowhead, please contact our business development team at BD@arrowheadpharma.com.